ArticleFrontiers in oncology2026
Early characterization of PSA dynamics in patients with metastatic hormone-sensitive prostate cancer receiving apalutamide-based regimens.
Peiyan Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.